Literature DB >> 20579124

Patient organizations in Finland: increasing numbers and great variation.

Hanna K Toiviainen1, Lauri H Vuorenkoski, Elina K Hemminki.   

Abstract

OBJECTIVE: There is very little research on patient organizations (POs), even though their numbers and influence seem to be increasing. The purpose of this study was to describe the establishment, membership, size, organization, decision making and basic funding of national POs in Finland. SETTING AND PARTICIPANTS: National POs (n = 130) were identified from their umbrella organizations and by Internet searches. Data were collected from POs' web pages (87% of POs had one), Finland's Slot Machine Association (RAY, an important public financier of POs), a relevant survey done by a local TV-company, and interviews and written materials of POs. RESULTS AND
CONCLUSIONS: Some current national POs were established around the turn of the 19(th) century. The rate of establishment of new POs increased from the 1970s and particularly in the 1990s when POs were characterized by increasing specialization. POs focused on different patient groups and diseases and were founded by philanthropists, physicians, patients, parents and the drug industry. Members could be patients, patient relatives, health-care professionals and organizations. POs widely varied in memberships (20-145 000, in 2002) and in number of paid personnel (0-1395, in 2002), organizational structure and decision making. Interest groups and financiers were often represented in decision-making organs. Activities included mutual support and service production, and, increasingly, informing and lobbying. POs had wide domestic and international co-operation and networking. Drug industry marketing was visible on PO web pages. Budget sizes varied (4000-15 million euros, in 2001). The main public financier was RAY. The old national POs were large and part of national social and health care, but newer ones were often established for mutual support and lobbying. National POs are not uniform but characterized by great variation. The number of national POs is increasing suggesting tighter competition for financing and visibility in the future.

Entities:  

Mesh:

Year:  2010        PMID: 20579124      PMCID: PMC5060534          DOI: 10.1111/j.1369-7625.2008.00499.x

Source DB:  PubMed          Journal:  Health Expect        ISSN: 1369-6513            Impact factor:   3.377


  22 in total

1.  Value and effectiveness of consumer advocacy groups: a survey of the anxiety disorders support group in South Africa.

Authors:  D J Stein; C Wessels; N Zungu-Dirwayi; M Berk; Z Wilson
Journal:  Depress Anxiety       Date:  2001       Impact factor: 6.505

Review 2.  Acknowledging the expertise of patients and their organisations.

Authors:  J Wilson
Journal:  BMJ       Date:  1999-09-18

3.  Involving patients: representation or representativeness?

Authors:  Angela Coulter
Journal:  Health Expect       Date:  2002-03       Impact factor: 3.377

4.  The role of women's advocacy groups in breast cancer.

Authors:  M Buchanan
Journal:  Breast       Date:  2003-12       Impact factor: 4.380

5.  Social movements in health: an introduction.

Authors:  Phil Brown; Stephen Zavestoski
Journal:  Sociol Health Illn       Date:  2004-09

6.  Framing as a cultural resource in health social movements: funding activism and the breast cancer movement in the US 1990-1993.

Authors:  Emily S Kolker
Journal:  Sociol Health Illn       Date:  2004-09

7.  Pharmaceuticals and the consumer movement: the ambivalences of 'patient power'.

Authors:  Hans Lofgren
Journal:  Aust Health Rev       Date:  2004-11-08       Impact factor: 1.990

8.  Health consumer groups in the UK: a new social movement?

Authors:  Judith Allsop; Kathryn Jones; Rob Baggott
Journal:  Sociol Health Illn       Date:  2004-09

Review 9.  Advocacy groups for breast cancer patients.

Authors:  M Waller; S Batt
Journal:  CMAJ       Date:  1995-03-15       Impact factor: 8.262

Review 10.  The advocacy movement in gynecologic oncology.

Authors:  Susan Vogt Temple
Journal:  Semin Oncol Nurs       Date:  2002-08       Impact factor: 2.315

View more
  3 in total

1.  Representing Whom? U.K. Health Consumer and Patients' Organizations in the Policy Process.

Authors:  Rob Baggott; Kathryn L Jones
Journal:  J Bioeth Inq       Date:  2018-05-25       Impact factor: 1.352

2.  Analysis of patient organizations' needs and ICT use--The APTIC project in Spain to develop an online collaborative social network.

Authors:  Eulàlia Hernández-Encuentra; Beni Gómez-Zúñiga; Noemí Guillamón; Mercè Boixadós; Manuel Armayones
Journal:  Health Expect       Date:  2014-03-05       Impact factor: 3.377

3.  Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?

Authors:  Dylan Pashley; Piotr Ozieranski; Shai Mulinari
Journal:  Int J Health Serv       Date:  2022-03-01       Impact factor: 1.851

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.